Genestra Brands¿ Multi GYN
Natural health product licensed in Canada
- Other names
- Genestra Brands¿ Formula GYN
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 01995987
- Status
- Inactive licence
- Licence date
- 9 December 2009
- Revision date
- 15 February 2010
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 105 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 105 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 105 mg | 105,000 µg |
| Magnésium Source : Oxyde de magnésium | 50 mg | 50,000 µg |
| Magnésium Source : Aspartate de magnésium | 50 mg | 50,000 µg |
Non-medicinal ingredients
Pharmaceutical Glaze, Angelica sinensis, Ovaire, Hypothalamus, Pituitary, Ribes nigrum, Microcrystalline cellulose, silice, Stéarate de magnésium, Dioscorea villosa, Calcium phosphate, Turnera aphrodisiaca, Crosscarmellose sodium, Actaea racemosa
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps the body to metabolize carbohydrates, fats and proteins and helps in tissue formation; helps in the development and maintenance of bones and teeth and helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 01995987
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging